| A new CDC study looking at human papillomavirus (HPV) vaccination during pregnancy was published in the journal Vaccine this week. |
| Researchers reviewed reports to the Vaccine Adverse Event Reporting System (VAERS) about women who received the HPV vaccine Gardasil® while they were pregnant. Gardasil® is not currently recommended for pregnant women, given the limited available safety data in pregnancy. However, because catchup vaccination is recommended for women through age 26, there is a possibility that some women will receive the vaccine before realizing that they are pregnant. This study found no patterns of safety concerns for pregnant woman who received Gardasil®, or for their babies. | |
| This study adds to the literature on the safety of HPV vaccination during pregnancy. Gardasil®’s manufacturer, Merck, maintained a Gardasil® Pregnancy Registry from 2006 to 2012. No safety concerns were noted in this registry. For more information on HPV vaccine safety, see: http://www.cdc.gov/ | |
Vaccine Adverse Event Reporting System (VAERS)
Vaccines are developed with the highest standards of safety. However, as with any medical procedure, vaccination has some risks. Individuals react differently to vaccines, and there is no way to predict how individuals will react to a particular vaccine.
The National Childhood Vaccine Injury Act (NCVIA) requires health care providers to report adverse events (possible side effects) that occur following vaccination, so the Food and Drug Administration (FDA)
and Centers for Disease Control and Prevention (CDC)established the Vaccine Adverse Events Reporting System (VAERS) in 1990. VAERS is a national passive reporting system that accepts reports from the public on adverse events associated with vaccines licensed in the United States. VAERS data are monitored to–
and Centers for Disease Control and Prevention (CDC)established the Vaccine Adverse Events Reporting System (VAERS) in 1990. VAERS is a national passive reporting system that accepts reports from the public on adverse events associated with vaccines licensed in the United States. VAERS data are monitored to–- Detect new, unusual, or rare vaccine adverse events
- Monitor increases in known adverse events
- Identify potential patient risk factors for particular types of adverse events
- Identify vaccine lots with increased numbers or types of reported adverse events
- Assess the safety of newly licensed vaccines
Approximately 30,000 VAERS reports are filed annually, with 10-15% classified as serious (resulting in permanent disability, hospitalization, life-threatening illnesses or death). Anyone can file a VAERS report, including health care providers, manufacturers, and vaccine recipients or their parents or guardians. The VAERS form requests the following information:
- The type of vaccine received
- The timing of the vaccination
- The onset of the adverse event
- Current illnesses or medication
- Past history of adverse events following vaccination
- Demographic information about the recipient
VAERS forms can be completed online, or you can complete a paper form and mail or fax it to VAERS.
A contractor, under the supervision of FDA and CDC, enters the information from VAERS forms into a database. Those reporting an adverse event to VAERS receive a confirmation letter containing a VAERS identification number. Additional information may be submitted to VAERS using the assigned identification number. Selected cases of serious adverse reactions are followed up at 60 days and one year post-vaccination to check the recovery status of the patient. FDA and CDC use VAERS data to monitor vaccine safety and conduct research studies. VAERS data (without identifying personal information) are also available to the public.
While VAERS provides useful information on vaccine safety, the data are somewhat limited. For example, VAERS reports may provide incomplete information. Specifically, judgments about whether the vaccine was truly responsible for an adverse event cannot be made from VAERS reports.
Reporting Vaccine Adverse Events
Anyone who gives or receives a licensed vaccine in the U.S. is encouraged to report any significant health problem or unexpected event (even if uncertain that the vaccine caused the event) for any vaccine. The Reportable Events Table (RET) lists and explains injuries and conditions that are believed to be caused by vaccines, and time periods in which the first symptom must occur after receiving the vaccine. It is used by the Vaccine Injury Compensation Program, which is operated by the U.S. Health Resources and Services Administration. Health care providers are required by law to report to VAERS any conditions on the RET, vaccine adverse events that are listed in the manufacturer's package insert, and clinically significant or unexpected events following vaccination.
National Surveillance Data for Vaccine Adverse Events
When evaluating data from VAERS, it is important to note that for any reported event, no cause-and-effect relationship has been established. VAERS receives reports on all potential associations between vaccines and adverse events. Therefore, VAERS collects data on any adverse event following vaccination, be it coincidental or truly caused by a vaccine. The report of an adverse event to VAERS is not documentation that vaccine caused the event.
.png)
No hay comentarios:
Publicar un comentario